HIG
70
4
UNM
71
5
TRV
45
3
KLAC
59
2
VFC
72
6
ADM
28
3
NAVI
40
8
BEN
30
-7
BK
69
4
ZION
59
7
F
40
2
MAT
56
5
TRIP
54
5
TXN
45
3
EA
41
3
SCHW
40
7
CA
4
-8
MS
74
5
PNC
55
6
NWS
41
2
HIG
70
4
UNM
71
5
TRV
45
3
KLAC
59
2
VFC
72
6
ADM
28
3
NAVI
40
8
BEN
30
-7
BK
69
4
ZION
59
7
F
40
2
MAT
56
5
TRIP
54
5
TXN
45
3
EA
41
3
SCHW
40
7
CA
4
-8
MS
74
5
PNC
55
6
NWS
41
2
Financhill
Back

ANI Pharmaceuticals Quote, Financials, Valuation and Earnings

AI Tech Innovator Poised for Strategic Buyouts Invest Now

Learn More
Sell
41

ANIP
ANI Pharmaceuticals

Last Price:
57.88
Seasonality Move:
2.08%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ANI Pharmaceuticals Price Quote

$57.88
+0.05 (+1.92%)
(Updated: October 5, 2024 at 6:16 AM ET)

ANI Pharmaceuticals Key Stats

Sell
41
ANI Pharmaceuticals (ANIP) is a Sell
Day range:
$57.44 - $58.30
52-week range:
$48.20 - $70.81
Dividend yield:
0%
P/E ratio:
68.04
P/S ratio:
2.07
P/B ratio:
2.67%
Volume:
74.3K
Avg. volume:
394.6K
1-year change:
0.59%
Market cap:
$1.2B
Revenue:
$486.8M
EPS:
$1.15

How Much Does ANI Pharmaceuticals Make?

Is ANI Pharmaceuticals Growing As A Company?

  • What Is ANI Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is ANI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ANI Pharmaceuticals Stock Price Performance

What Is ANI Pharmaceuticals 52-Week High & Low?

ANI Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ANI Pharmaceuticals?

Is ANI Pharmaceuticals Cash Flow Positive?

  • What Is ANIP Cash Flow From Operations?
    Cash flow from operations (TTM) is $112.6M
  • What Is ANI Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$29.3M
  • What Is ANI Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.8M

ANI Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ANIP return on invested capital is 3.62%
  • What Is ANI Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 3.01%
  • What Is ANIP Return On Equity?
    ROE is a measure of profitability and is 5.86%

ANI Pharmaceuticals Earnings Date & Stock Price

ANI Pharmaceuticals Competitors

ANI Pharmaceuticals Dividend Yield

ANI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.37%
Revenue: 18.44% 6.96%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 82.40
Upside from Last Price: 42.49%

Major Shareholders

  • How many ANIP shares are owned by institutional investors?
    22.8M ANIP shares are owned by institutional investors
  • How many ANIP shares are owned by insiders?
    2.7M ANIP shares are owned by insiders